Actively Recruiting

Age: 18Years +
All Genders
ID05893407

Quantification of Cerebral Perfusion at the Patient's Bedside Using Contrast-Enhanced Ultrasound in Neurointensive Care Patients

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-06-19

60

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating brain tissue perfusion in patients with acute brain injuries using contrast-enhanced ultrasound perfusion imaging (PerCEUS). This study aims to assess the unevenness of brain blood flow to diagnose areas of poor perfusion and to compare these findings with standard multimodal monitoring techniques. The study focuses on patients admitted to neurointensive care with confirmed acute brain injuries. The PerCEUS procedure involves using a specialized ultrasound machine to perform imaging at the patient's bedside, targeting specific brain regions identified by MRI or CT scans. The imaging captures detailed perfusion data within about 5 minutes, focusing on the lesion core, surrounding tissue, and the corresponding area in the opposite hemisphere. This imaging is done alongside routine monitoring methods such as intracranial pressure, cerebral perfusion pressure, arterial pressure, cerebral oxygen saturation, and jugular venous oxygen levels. Participants undergo the PerCEUS imaging shortly after hospital admission when contrast ultrasound is needed, without delaying emergency care. The study session lasts approximately 30 minutes, including 25 minutes of observation after the imaging. Researchers analyze the data offline, measuring perfusion heterogeneity through time-to-peak and peak intensity, and correlate these with standard monitoring results. The study concludes with safety oversight, aiming to improve understanding of brain blood flow in acute injury situations.

CONDITIONS

Brief Title

Brain PERfusion Evaluation by Contrast-Enhanced UltraSound

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Admission to intensive care unit for acute brain injury
  • Confirmed acute brain injury by CT and/or MRI
  • Requires contrast ultrasound imaging
  • Informed consent provided by patient or relative
Not Eligible

You will not qualify if you...

  • Pregnancy
  • Insufficient temporal window for ultrasound
  • Contraindications to Sonovue® such as acute coronary syndromes, severe ischemic heart disease requiring revascularization, pulmonary arterial hypertension above 90 mmHg, right-left shunt, ARDS, use of dobutamine, or known allergy to Sonovue®
  • Patient on State Medical Assistance

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 30 minutes

Participants undergo contrast-enhanced ultrasound perfusion imaging (PerCEUS) at the bedside to evaluate brain perfusion heterogeneity and correlate with multimodal monitoring parameters.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Lariboisière Hospital

Paris, France, 75010

Actively Recruiting

Loading map...

Research Team

R

Romain BARTHELEMY, MD

B

Benjamin Glenn CHOUSTERMAN, MD PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

18F FDG and 68Ga FAPI PET/MR Imaging of Carotid Artery Plaqu...

Carotid Artery Plaque

Actively Recruiting

1 location

Pilot Study of 3D Ultrasound Localization Microscopy to Dete...

Subarachnoid Hemorrhage

Actively Recruiting

1 location

Efficacy and Safety of Bevifibatide Citrate Injection in Pat...

Ischemic Stroke, Acute

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Detection of cerebral perfusion abnormalities in acute stroke using phase inversion harmonic imaging (PIHI): preliminary results.

J Eyding, C Krogias, W Wilkening...

https://pubmed.ncbi.nlm.nih.gov/15146019

Potential of Contrast-Enhanced Ultrasound as a Bedside Monitoring Technique in Cerebral Perfusion: a Systematic Review.

Elisabeth J Vinke, Anna J Kortenbout, Jens Eyding...

https://pubmed.ncbi.nlm.nih.gov/28964614

Ultrasound Perfusion Imaging for the Detection of Cerebral Hypoperfusion After Aneurysmal Subarachnoid Hemorrhage.

Christian Fung, Dieter Henrik Heiland, Raluca Reitmeir...

https://pubmed.ncbi.nlm.nih.gov/35211837